Pallas Health vs Wellmedr: Which GLP-1 Plan Fits You
Pallas Health vs Wellmedr compares two online GLP-1 providers with different pricing, medication options and review workflows. Early verdict: Pallas is best if you want a clinician to choose between brand-name pens and US-compounded preparations with a single intake; Wellmedr is best if you prefer lower advertised monthly starts, monthly shipping cadence and lifetime locked pricing.
Start Pallas Health intake and clinician review
Key differences at a glance for Pallas Health vs Wellmedr
Below are the most distinctive supported differences: pricing and cadence, medication selection and formulation, clinician review and visit requirements, pricing guarantees and refund claims, and shipping and renewal terms.
1. Pricing structure and billing cadence
Pallas Health publishes compounded semaglutide at $139 for the first month, then $597 every 12 weeks for a $199 per month average; compounded tirzepatide is $179 first month, then $897 every 12 weeks for a $299 per month average. Pallas also lists cash-pay brand-name options with monthly cash prices. Pallas prices compounded plans by medication so titration does not raise the plan price.
Wellmedr advertises GLP-1 plans starting at $89 per month and monthly shipping. Wellmedr also promotes promotional offers such as a Labor Day sale or lifetime locked-in pricing claims and a money back guarantee as presented on its landing page.
See Wellmedr monthly plans and offers
2. Medication options and formulation
Pallas offers both FDA-approved brand-name GLP-1s including Wegovy, Ozempic, Zepbound and Mounjaro and clinician-personalized compounded semaglutide or tirzepatide prepared in the USA when a brand medication is not the right fit. Pallas notes that compounded medications are prepared by US-licensed compounding pharmacies and are not FDA-approved.
Wellmedr offers compounded GLP-1 medications from licensed U.S. pharmacies and similarly notes that compounded medications are regulated by state Boards of Pharmacy and are not evaluated by the FDA for safety or efficacy. Wellmedr lists semaglutide and tirzepatide plans and also shows brand-name pricing for some FDA-approved pens.
Compare Pallas brand and compounded options
3. Clinician review and visit requirements
Pallas says a US-licensed clinician reviews your health history and personalizes the plan and that the service is 100 percent online and asynchronous in most states with video visits required in seven states plus Washington D C. Wellmedr promotes same-day review for new customers and requires clinician approval; the captured content emphasizes that all treatment plans require medical evaluation and clinician approval.
4. Pricing guarantees, promotions and refunds
Pallas states plan prices include provider care and messaging with no membership fee and that refunds are offered in full if a clinician decides treatment is not right for you. Wellmedr shows marketing claims including lifetime locked-in pricing and a money back guarantee for weight loss within 90 days as presented on its site. These are provider claims captured on the landing pages and should be confirmed before enrollment.
5. Shipping, renewals and cancellation notes
Pallas offers free expedited and discreet shipping and notes compounded plans renew every 12 weeks rather than monthly, so cancellation timing matters. Pallas is cash-pay only and does not bill insurance. Wellmedr advertises free overnight or guaranteed on-time refills with monthly shipments and allows cancel or change anytime on monthly plans per the captured copy.
| Criteria | Pallas Health | Wellmedr |
|---|---|---|
| Starting price (compounded) | $139 first month semaglutide | Semaglutide from $49 to $89/mo per landing page |
| Billing cadence | Compounded renewals every 12 weeks (avg $199/mo) | Monthly plans and monthly shipping |
| Brand-name options | Offers Wegovy, Ozempic, Zepbound, Mounjaro | Lists brand-name pricing for some pens |
| Compounded meds | Compounded in USA; not FDA-approved | Compounded from US pharmacies; not FDA-evaluated |
| Clinician review | US-licensed clinician review; mostly asynchronous | Clinician approval required; same-day review advertised |
| Price guarantees | No membership fee; plan includes provider care; refunds if clinician declines | Claims lifetime locked pricing and money back guarantee on landing page |
What to watch for in Pallas Health vs Wellmedr
Regulatory note appears for both: compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Pallas specifies cash-pay only and that FSA HSA use needs a Letter of Medical Necessity. Wellmedr includes a safety notice about potential GLP-1 medication risks as presented on its site. Where details such as state eligibility, exact renewal totals and current promotions matter, confirm the provider pages before enrolling.
Check Wellmedr eligibility and terms
Conclusion and short verdict on Pallas Health vs Wellmedr
In direct comparison, Pallas Health centers on clinician choice between FDA-approved pens and US-compounded preparations with 12-week compounded renewals and an all-in plan price that includes provider care. Wellmedr centers on lower advertised monthly starts, monthly shipping cadence, and prominent lifetime-locked pricing or promotional claims on its landing page. Both note that compounded medications are not FDA-approved and both require clinician review.
Choose Pallas Health if…
you want a single intake where a US-licensed clinician can choose between brand-name GLP-1 pens and a clinician-personalized US-compounded semaglutide or tirzepatide, prefer an all-in plan price with provider care included, and accept 12-week compounded renewals and cash-pay only terms.
Choose Wellmedr if…
you prioritize lower advertised monthly starting prices, monthly shipping and plans, and the marketing claims of lifetime locked pricing or a money back guarantee as presented on the provider landing page. Confirm eligibility, renewal terms and current promotions before enrolling.